Subsequently, tRF‐34‐P4R8YP9LON4VHM could enhance HCC proliferation, migration, invasion, and tumour cell‐induced angiogenesis by activating the MEK/ERK signalling pathway and promoting the secretion of VEGFA. Here, MAP2K7 is linked to neoplasm.